Christopher Talutis

Christopher Talutis is an experienced marketing professional with a focus on the pharmaceutical industry. Currently serving as Director of US Marketing and Genetic Diseases Lead at Rhythm Pharmaceuticals Inc. since May 2025, Talutis previously held key roles at X4 Pharmaceuticals and Ipsen, where responsibilities included leading pipeline marketing initiatives and managing various aspects of neuroscience marketing. At Regeneron Pharmaceuticals, Inc., significant contributions were made in commercial analytics, particularly for products such as DUPIXENT and KEVZARA, through collaborative efforts in brand planning and commercialization strategies. Early career experience includes an internship at Thermo Fisher Scientific, where market analyses and strategic marketing plans were developed. Talutis holds an MBA from Georgetown University McDonough School of Business and a BS in Biochemistry from Boston College.